Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma
- 7 January 2015
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (8) , 2669-2676
Abstract
Mucinous carcinoma (MC) is a distinct form of rectal cancer (RC) comprising 10 % of all cases and has been associated with an impaired prognosis compared with non-mucinous adenocarcinoma (AC). The benefit of today’s modern treatment for MC patients is unknown but a prospective randomized trial to answer this does not seem feasible. This study provides an analysis of the modern treatment of rectal MC and efficacy of preoperative therapies for MC patients. Data from three large (trial) cohorts were used. Data from the Netherlands Cancer Registry (NCR) were used to analyze the prognosis of RC patients over time (N = 38,035). To study the benefit of preoperative short-term radiotherapy, patients from the total mesorectal excision (TME) trial (N = 1,530) were selected, and the benefit from preoperative chemoradiotherapy was analyzed with data on 540 locally advanced RC (LARC) patients from two hospitals. Data from the NCR confirmed that 5-year overall survival for MC was significantly worse from 1989 to 1998, but no longer different from AC from 1999 onwards. MC patients had a higher rate of positive circumferential resection margin than AC patients (TME trial 27.2 vs. 16.5 %, p = 0.006; LARC cohort 34.5 vs. 9.8 %, p < 0.0001), but there was no difference in outcome between MC and AC patients after preoperative short-term radiotherapy or chemoradiotherapy. Modern treatment of RC has benefited MC patients, leading to equal survival for MC and AC patients. Enhancements in the fields of imaging and quality of surgery have improved outcome and preoperative therapies should be recommended for both histological subtypes.Keywords
This publication has 42 references indexed in Scilit:
- Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancerBritish Journal of Surgery, 2013
- Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data BaseAnnals of Surgical Oncology, 2012
- Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal CancerAnnals of Surgery, 2011
- Mucinous Rectal Cancer: Effectiveness of Preoperative Chemoradiotherapy and PrognosisAnnals of Surgical Oncology, 2011
- Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989–2006European Journal of Cancer, 2010
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapyBritish Journal of Cancer, 2007
- Mucinous Rectal Adenocarcinoma Can Be Associated to Tumor Downstaging after Preoperative ChemoradiotherapyDiseases of the Colon & Rectum, 2007
- Effects of radiotherapy on different histopathological types of rectal carcinomaColorectal Disease, 2006
- Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviourThe Journal of Pathology, 2004